d75_4157

Overview

The Auxiliary Board has committed more than $2,000,000 to enhance treatment for patients and their families through a host of patient care initiatives at Northwestern Memorial Hospital. Since 1987, we have focused on providing seed money to programs and research initiatives, including the Ambulatory Spine Program, Bone Marrow Transplant, Comprehensive Heart Failure Prevention and Treatment, Neurology and Neurological Surgery, Prostate Cancer Gene Therapy, Women’s Health and the Northwestern Brain Tumor Institute.


Current Initiative: Novel Type 1 Diabetes Research

The Auxiliary Board of Northwestern Memorial Hospital recently pledged its support to a novel research study of type 1 diabetes, led by Jing Jin, MD, PhD in the Division of Nephrology/Hypertension at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine.

Often diagnosed in children and young adults, patients afflicted with type 1 diabetes (T1D) need lifelong treatment with insulin and are prone to debilitating and life-threatening complications, including heart disease, stroke and kidney malfunction. T1D is classified as an autoimmune disorder, which occurs when the immune system fails to recognize certain cells of the body as “self” and goes on the attack.

Aiming to improve the understanding of autoimmunity in T1D, Dr. Jin’s team discovered in diabetic mouse models that insulin does sometimes undergo a chemical mutation that causes it to be attacked. His team’s hypothesis is that, when present, attacking antibodies may serve as diagnostic markers and therapeutic targets for humans with T1D. The marker (test) developed in Dr. Jin’s study will be the first of its kind to aid in T1D diagnosis and risk assessment.

Over the past two years, more than 3,000 people have attended our events, yielding more than $100,000 for innovative research at Northwestern Memorial. To support Dr. Jin’s meaningful initiative, make a gift today.